Encompass Health Corporation $EHC Shares Sold by Hantz Financial Services Inc.

Hantz Financial Services Inc. lessened its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 17.4% in the fourth quarter, Holdings Channel reports. The firm owned 54,704 shares of the company’s stock after selling 11,538 shares during the period. Hantz Financial Services Inc.’s holdings in Encompass Health were worth $5,806,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Northwestern Mutual Wealth Management Co. increased its position in Encompass Health by 3,059,159.7% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. Alliancebernstein L.P. boosted its holdings in Encompass Health by 23.4% in the 3rd quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after acquiring an additional 476,564 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Encompass Health by 0.5% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,616,178 shares of the company’s stock worth $205,279,000 after acquiring an additional 7,349 shares during the period. Raymond James Financial Inc. boosted its holdings in Encompass Health by 34.8% in the 3rd quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after acquiring an additional 397,694 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in Encompass Health by 5.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 1,410,335 shares of the company’s stock worth $179,141,000 after acquiring an additional 70,387 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on EHC shares. Barclays decreased their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday. Finally, Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Two investment analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $145.29.

Encompass Health Stock Up 0.1%

NYSE EHC opened at $105.04 on Tuesday. The stock has a market cap of $10.42 billion, a PE ratio of 17.54, a P/E/G ratio of 2.29 and a beta of 0.72. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The business has a 50 day moving average price of $102.95 and a two-hundred day moving average price of $105.65. Encompass Health Corporation has a fifty-two week low of $92.77 and a fifty-two week high of $127.99.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, sell-side analysts predict that Encompass Health Corporation will post 5.96 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio is 12.69%.

Insider Activity at Encompass Health

In other news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.80% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.